Interestingly, in this model, TGF‐β inhibition led to increased CAF proliferation and to reduced PD‐L1 surface expression on tumor cells through MMP9‐mediated cleavage, suggesting a resistance mechanism for anti‐PD1 therapy.131. The gene discussed is PDCD1; the disease is neoplasm.